Psychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarin

Thrombosis and Haemostasis

Volumn 108, Issue 4, 2012, Pages 789-795

  Wang, Ye ^a   Kong, Ming Chai ^b   Ko, Yu ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Anticoagulation; Medication adherence; Morisky medication adherence scale; Warfarin

Indexed keywords

WARFARIN;

8 ITEM MORISKY MEDICATION ADHERENCE SCALE; ADULT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DIET; FEMALE; HUMAN; INTERNAL CONSISTENCY; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT PREFERENCE; PREDICTIVE VALUE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOMETRY; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; VALIDITY;

ADULT; AGED; ANTICOAGULANTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; LANGUAGE; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SINGAPORE; WARFARIN;

EID: 84867256254     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-05-0368     Document Type: Article

References (34)

1. Geerts WH, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 Suppl): 338S-400S.
2. Albers GW, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 Suppl): 483S-512S.
3. Ansell J, et al. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 Suppl): 204S-233S.
4. Baglin TP, et al. Guidelines on oral anticoagulation (warfarin): third edition--2005 update. Br J Haematol 2006; 132: 277-285.
5. Wittkowsky AK, Devine EB. Frequency and causes of overanticoagulation and underanticoagulation in patients treated with warfarin. Pharmacotherapy 2004; 24: 1311-1316.
6. Waterman AD, et al. Effect of warfarin nonadherence on control of the International Normalized Ratio. Am J Health Syst Pharm 2004; 61: 1258-1264.
7. Levine MN, et al. Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 Suppl): 287S-310S.
8. Merli GJ, Tzanis G. Warfarin: what are the clinical implications of an out-of-range-therapeutic international normalized ratio? J Thromb Thrombolysis 2009; 27: 293-299.
9. Hylek EM, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003; 349: 1019-1026.
10. Hixson-Wallace JA, et al. Effect of regimen complexity on patient satisfaction and compliance with warfarin therapy. Clin Appl Thromb Hemost 2001; 7: 33-37.
11. Kimmel SE, et al. The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study. Arch Intern Med 2007; 167: 229-235.
12. Rose AJ, et al. Epidemiology of subtherapeutic anticoagulation in the United States. Circ Cardiovasc Qual Outcomes 2009; 2: 591-597.
13. Glader EL, et al. Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke. Stroke 2010; 41: 397-401.
14. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 487-497.
15. Vermeire E, et al. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 2001; 26: 331-342.
16. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999; 21: 1074-1090.
17. Morisky DE, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 2008; 10: 348-354.
18. Morisky DE, et al. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67-74.
19. Korb-Savoldelli V, et al. Validation of a French Version of the 8-Item Morisky Medication Adherence Scale in Hypertensive Adults. J Clin Hypertens 2012; in press.
20. Sakthong P, et al. Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes. Ann Pharmacother 2009; 43: 950-957.
21. Al-Qazaz H, et al. The eight-item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian version. Diabetes Res Clin Pract 2010; 90: 216-221.
22. Trindade AJ, et al. Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence. Inflamm Bowel Dis 2011; 17: 599-604.
23. Reynolds K, et al. Psychometric properties of the osteoporosis-specific morisky medication adherence scale in postmenopausal women with osteoporosis newly treated with bisphosphonates. Ann Pharmacother 2012; 46: 659-670.
24. Orensky IA, Holdford DA. Predictors of noncompliance with warfarin therapy in an outpatient anticoagulation clinic. Pharmacotherapy 2005; 25: 1801-1808.
25. Cortina JM. What Is Coefficient Alpha? An Examination of Theory and Applications. J Appl Psychol 1993; 78: 98-104.
26. Hess LM, et al. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006; 40: 1280-1288.
27. Brown TA. Confirmatory Factor Analysis for Applied Research. The Guilford Press, New York; 2006.
28. Streiner DL. Health Measurement Scales: A Practical Guide to Their Development and Use. 3rd ed. Oxford University Press, USA; 2003.
29. Krousel-Wood M, et al. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 2009; 15: 59-66.
30. Natarajan N, et al. Family practice patients' adherence to statin medications. Can Fam Physician 2007; 53: 2144-2145.
31. Agh T, et al. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease. Respiration 2011; 82: 328-334.
32. Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med 2008; 31: 213-224.
33. Chiquette E, et al. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 1998; 158: 1641-1647.
34. Cohen AT, et al. Will a once-weekly anticoagulant for the treatment and secondary prevention of thromboembolism improve adherence? Thromb Haemost 2009; 101: 422-427.